 Connection
Hui Yu to Biomarkers
This is a "connection" page, showing publications Hui Yu has written about Biomarkers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.135 |
|
|
|
-
Suda K, Murakami I, Yu H, Kim J, Ellison K, Rivard CJ, Mitsudomi T, Hirsch FR. Heterogeneity in Immune Marker Expression after?Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung?Cancer Transformation. J Thorac Oncol. 2017 06; 12(6):1015-1020.
Score: 0.061
-
Yu H, Boyle TA, Zhou C, Rimm DL, Hirsch FR. PD-L1 Expression in Lung Cancer. J Thorac Oncol. 2016 07; 11(7):964-75.
Score: 0.058
-
Suda K, Murakami I, Yu H, Kim J, Tan AC, Mizuuchi H, Rozeboom L, Ellison K, Rivard CJ, Mitsudomi T, Hirsch FR. CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer. Mol Cancer Ther. 2018 10; 17(10):2257-2265.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|